Alumis Inc.
ALMS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847367
In the last 90 days, Alumis Inc. insiders filed 1 open-market purchase and 8 sales; 198 institutions reported holding it in 13F filings for Q2 2026, worth $3.32B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Alumis Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 112
- +40 vs. Q1 2025
- Shares held
- 78.3M
- +38.1M (+94.8%) vs. Q1 2025
- Total value
- $235.0M
- −$11.9M (−4.8%) vs. Q1 2025
- New holders
- 53
- 49 more added
- Sold out
- 13
- 2 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALMS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 198 | $3.32B |
| Q1 2026 | 197 | $2.53B |
| Q4 2025 | 134 | $771.1M |
| Q3 2025 | 130 | $311.2M |
| Q2 2025 | 112 | $235.0M |
| Q1 2025 | 72 | $246.8M |
| Q4 2024 | 64 | $316.5M |
| Q3 2024 | 52 | $376.1M |
| Q2 2024 | 29 | $380.0M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Alumis Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sr One Capital Management, LP | 1,959,896 | $5.88M | 1.27% | 00.0% | Unchanged |
| Tang Capital Management LLC | 1,996,797 | $5.99M | 0.30% | +1,996,797 | New |
| Cormorant Asset Management, LP | 2,147,396 | $6.44M | 0.48% | 00.0% | Unchanged |
| Trium Capital LLP | 2,648,039 | $7.94M | 1.98% | +2,648,039 | New |
| Nextech Invest, Ltd. | 2,915,998 | $8.75M | 1.66% | +1,439,000+97.4% | Added |
| Vanguard Group Inc | 3,404,211 | $10.2M | 0.00% | +2,467,015+263.2% | Added |
| BlackRock, Inc. | 4,175,713 | $12.5M | 0.00% | +2,717,986+186.5% | Added |
| Foresite Capital Management VI LLC | 4,247,670 | $12.7M | 7.16% | +45,000+1.1% | Added |
| venBio Partners LLC | 4,619,803 | $13.9M | 12.08% | +1,832,405+65.7% | Added |
| Samsara BioCapital, LLC | 4,801,370 | $14.4M | 2.95% | +1,534,872+47.0% | Added |
| Foresite Capital Management V, LLC | 5,779,348 | $17.3M | 21.48% | 00.0% | Unchanged |
| AyurMaya Capital Management Company, LP | 15,139,707 | $45.4M | 100.00% | +4,493,741+42.2% | Added |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −24,150−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −18,374−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −13,566−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −11,630−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −10,700−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −10,658−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −981−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −236−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −104−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |